Postlicensure Observational Safety Study of 13vPnC Administered to Infants

See also
Status	Clinical Trial	Phase
Completed	`NCT04546425` - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants	Phase 3
Recruiting	`NCT06044077` - A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People	Phase 3
Completed	`NCT02146365` - Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers
Completed	`NCT04525599` - A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator	Phase 1
Active, not recruiting	`NCT05512819` - A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan	Phase 3
Completed	`NCT04530838` - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants	Phase 3
Active, not recruiting	`NCT06026748` - A Phase I Study of XJ103 in Chinese Healthy Subjects	Phase 1
Completed	`NCT04526574` - Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age	Phase 3
Completed	`NCT05329259` - A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India	Phase 4
Completed	`NCT00234338` - Study Evaluating Prevenar in High-Risk Children	N/A
Completed	`NCT01767402` - Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults	Phase 1
Active, not recruiting	`NCT05569954` - Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)	Phase 3
Completed	`NCT01111214` - Child Pneumococcal Serotype Epidemiology In Greece	N/A
Completed	`NCT01298544` - A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers	Phase 4
Completed	`NCT04830358` - Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults	Phase 1
Completed	`NCT04379713` - 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants	Phase 3
Completed	`NCT04887948` - Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2	Phase 3
Completed	`NCT04382326` - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants	Phase 3
Not yet recruiting	`NCT00843895` - Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years	N/A
Completed	`NCT01734239` - A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)	Phase 3

NCT number	NCT01128426
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase	N/A
Start date	June 2010
Completion date	June 2013

Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms